MICROSCAN LABPRO INFORMATION MANAGER SYSTEM (2015-07-21) — recall 54029
Health Canada — Medical Devices · Canada · 2015-08-10 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Beckman coulter has confirmed the following issues can be encountered when generating organism identifications in the Microscan Labpro information manager system from dried overnight gram negative panels processed on Microscan Autoscan-4 Systems or read manually and entered into the Labpro System. The use of dried overnight gram negative panels and the Labpro Software System on the Walkaway system is not affected. Some glucose non-fermenting organisms may display a color change (shade of yellow) in the GLU, SUC, and SOR at 48 hours. When this occurs: Labpro software incorrectly allows the operator to manually edit the carbohydrate substrates (specifically GLU, SUC, and SOR) when manually reading dried overnight gram negative (conventional) panels with an ID hold status. Labpro software incorrectly overwrites the previously stored carbohydrate substrate results (specifically GLU, SUC, and SOR) when reading dried gram negative overnight (conventional) panels which have an ID hold status on the Autoscan-4 System. Labpro software then incorrectly uses the fermenter identification substrates to calculate the biotype which may cause non-fermenters such as an Acinetobacter species to be incorrectly identified as fermenters, for example, a Shigella species.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.